Søgeresultater - Johan Blakkisrud

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Radionuclides for Targeted Therapy: Physical Properties

    Radionuclides for Targeted Therapy: Physical Properties af Caroline Stokke, Monika Kvassheim, Johan Blakkisrud

    Udgivet 2022
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [<sup>177</sup>Lu]Lu-DOTATATE

    SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [<sup>177</sup>Lu]Lu-DOTATATE af Johan Blakkisrud, Avery Peterson, S.J. Wildermann, Griffen Kingkiner, Ka Kit Wong, Chang Wang, Kirk A. Frey, Caroline Stokke, Yuni K. Dewaraja

    Udgivet 2024
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials

    EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials af Caroline Stokke, Silvano Gnesin, Johannes Tran‐Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix M. Mottaghy, Jonathan Gear

    Udgivet 2024
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

    Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma af Arne Kolstad, Tim Illidge, Nils Bolstad, Signe Spetalen, Ulf Madsbu, Caroline Stokke, Johan Blakkisrud, Ayca Muftuler Løndalen, N. O’Rourke, Matthew Beasley, Wojciech Jurczak, Unn‐Merete Fagerli, Michal Kaščák, M. Bayne, Aleš Obr, Jostein Dahle, Lisa Rojkjaer, Véronique Pascal, Harald Holte

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: